| Jan 21, 2014
| 10:32 PM
SAN FRANCISCO — A federal appeals court became the first in the nation to rule that prospective jurors may not be excluded because of their sexual orientation, a decision that expands juror protections beyond race and gender and provides legal...
| Jan 24, 2014
| 3:12 PM
In a decision with wide-reaching implications, a federal appeals court ruled this week that potential jurors cannot be left off of juries based on their sexual orientations.
Remember the antitrust case involving two purveyors of HIV/AIDS drugs that...
| Nov 25, 2013
| 4:52 PM
Avandia, a controversial diabetes drug that was thought to increase patients’ risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration.
Federal regulators said Monday that the...
| Apr 22, 2014
| 8:31 AM
Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
| Apr 7, 2014
| 11:04 AM
British drug-maker GlaxoSmithKline said it is launching an investigation into claims of misconduct in Iraq.
The announcement comes months after China began looking into allegations of a bribery ring within the company's business in that country.
| Mar 27, 2014
| 11:17 AM
Staffers passing by a room in the U.S. House of Representatives office building earlier this month did double takes. Whom they saw inside were no ordinary Capitol Hill briefing attendees: rats, mice, guinea pigs and rabbits.
The presence of these...
| Mar 2, 2014
| 6:00 AM
BEIJING — The headline news on state-run Chinese Channel 13 was juicy: A mining tycoon and 35 others had been charged with running a mafia-style enterprise in Sichuan province, gunning down enemies in the street, bribing people and operating an...
| Feb 5, 2014
| 5:11 PM
CVS Caremark Corp.'s imminent exit from the cigarette and tobacco business — an unprecedented move for a major pharmacy company — is being cheered by many medical professionals and lawmakers as a triumph of corporate responsibility over the...
| Dec 17, 2013
| 7:44 AM
Ending a practice that some say creates a conflict of interest, British pharmaceutical company GlaxoSmithKline said Tuesday it would end its practice of paying doctors to promote its drugs.
Glaxo, maker of drugs such as the antidepressant Paxil, also...
| Apr 24, 2014
| 8:41 AM
Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.
The proposed acquisition follows a flurry of billion-dollar deals by...
| Apr 30, 2012
| 5:35 PM
Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...